메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Yu Jun Wong (Department of Gastroenterology & Hepatology Changi General Hospital) Chen Zhaojin (Biostatistics Unit Yong Loo Lin School of Medicine National University of Singapore) Guilia Tosetti (Division of Gastroenterology and Hepatology Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico) Elisabetta Degasperi (Division of Gastroenterology and Hepatology Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico) Sanchit Sharma (Department of Gastroenterology and Human Nutrition Unit All India Institute of Medical Science) Samagra Agarwal (Department of Gastroenterology and Human Nutrition Unit All India Institute of Medical Science) Liu Chuan (CHESS Center Institute of Portal Hypertension the First Hospital of Lanzhou University) Chan Yiong Huak (Biostatistics Unit Yong Loo Lin School of Medicine National University of Singapore) Li Jia (Department of Gastroenterology & Hepatology Tianjin Second People’s Hospital) Qi Xiaolong (CHESS Center Institute of Portal Hypertension the First Hospital of Lanzhou University) Anoop Saraya (Department of Gastroenterology and Human Nutrition Unit All India Institute of Medical Science) Massimo Primignani (Division of Gastroenterology and Hepatology Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico)
저널정보
대한간학회 Clinical and Molecular Hepatology Clinical and Molecular Hepatology 제29권 제1호
발행연도
2023.1
수록면
135 - 145 (11page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background/Aims: The utility of Baveno-VII criteria of clinically significant portal hypertension (CSPH) to predict decompensation in compensated advanced chronic liver disease (cACLD) patient needs validation. We aim to validate the performance of CSPH criteria to predict the risk of decompensation in an international real-world cohort of cACLD patients. Methods: cACLD patients were stratified into three categories (CSPH excluded, grey zone, and CSPH). The risks of decompensation across different CSPH categories were estimated using competing risk regression for clustered data, with death and hepatocellular carcinoma as competing events. The performance of “treating definite CSPH” strategy to prevent decompensation using non-selective beta-blocker (NSBB) was compared against other strategies in decision curve analysis. Results: One thousand one hundred fifty-nine cACLD patients (36.8% had CSPH) were included; 7.2% experienced decompensation over a median follow-up of 40 months. Non-invasive assessment of CSPH predicts a 5-fold higher risk of liver decompensation in cACLD patients (subdistribution hazard ratio, 5.5; 95% confidence interval, 4.0–7.4). “Probable CSPH” is suboptimal to predict decompensation risk in cACLD patients. CSPH exclusion criteria reliably exclude cACLD patients at risk of decompensation, regardless of etiology. Among the grey zone, the decompensation risk was negligible among viral-related cACLD, but was substantially higher among the non-viral cACLD group. Decision curve analysis showed that “treating definite CSPH” strategy is superior to “treating all varices” or “treating probable CSPH” strategy to prevent decompensation using NSBB. Conclusions: Non-invasive assessment of CSPH may stratify decompensation risk and the need for NSBB in cACLD patients.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0